January 2023 in “Annals of Dermatology” Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.
4 citations
,
January 2002 in “Annals of Dermatology” Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.
January 2026 in “Annals of Dermatology” Alitretinoin may help treat mild to moderate alopecia areata.
18 citations
,
January 2013 in “Annals of Dermatology” AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.
1 citations
,
January 2012 in “Daehan namseong gwahag hoeji” Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.
December 2025 in “Mendeley Data” December 2025 in “Mendeley Data”
January 2025 in “Investigative and Clinical Urology” SHPro® improved urinary symptoms and erectile function in men and is safe.
January 2024 in “Scripta Medica” Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.
More hair-loss studies are needed with standardized outcomes and diverse participants.
April 2026 in “Mendeley Data” April 2026 in “Mendeley Data” June 2026 in “International Journal of Computational and Biological Sciences” A new tool using ultrasound and clinical data better predicts early diabetic kidney injury.
A rapid screening method using trichoscopy and clinical data can improve diagnosis and treatment of tinea capitis.
June 2025 in “Jurnal Bumigora Information Technology (BITe)” Naive Bayes algorithm can help predict hair loss risk early.
January 2021 in “Figshare” Coenzyme Q10 in nanocarriers improves treatment for hair loss.
31 citations
,
November 2009 in “European journal of dermatology/EJD. European journal of dermatology” Experts made a guide to help doctors evaluate women with too much hair growth.
2 citations
,
November 2020 in “Hair transplant forum international” Exosomes might be a promising new treatment for hair loss.
8 citations
,
August 2016 in “Expert opinion on pharmacotherapy” New, safer treatments for children's hair disorders are needed, and better evaluation methods are recommended.
3 citations
,
January 2019 in “Electronic Imaging” The device accurately estimates natural hair color at the roots in real time.
3 citations
,
March 2017 in “International Journal of Ayurvedic Medicine” Bhrungaraj (Eclipta alba) shows potential for drug development based on its traditional uses and pharmacological evidence.
2 citations
,
June 2022 in “Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica” Understanding cultural hair care practices is essential for improving hair health in the African American population.
PRP therapy is promising for hair loss but needs standardized methods and personalization.
September 2024 in “Journal of Education Health and Sport” PRP therapy can help regrow hair and improve hair thickness.
June 2022 in “Frontiers in Medicine” Acupuncture and moxibustion may help treat hair loss, but more research is needed.
January 2020 in “International Journal of Medical Research and Health Sciences” Many female students at Northern Border University in Saudi Arabia may have Polycystic ovary syndrome (PCOS) and related emotional distress, so those at risk should get further tests and treatment.
4 citations
,
January 2019 in “Elsevier eBooks” Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.
1 citations
,
January 2020 in “Aesthetic Surgery Journal” Platelet-rich plasma and stem cell therapies are accepted treatments for hair restoration, with specific protocols recommended for best results, but more standardization is needed in stem cell use.
1 citations
,
June 2017 in “International Journal of Toxicology” Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.
June 2026 in “Dove Medical Press (Taylor and Francis Group)” JAK inhibitors show promise for treating alopecia areata, but long-term safety and emotional support are important.